Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Today, the Company signed an agreement that enables an increased pace for implementation of the new strategy through loans from two lenders of a maximum of mSEK 10.
The agreement strengthens the Company's finances and creates opportunities to begin and complete the strategy that the company developed during the year.
This new credit gives Scandinavian ChemoTech more scope to reach new milestones.
The loan is raised on market terms.
"That, in today's situation, be given the opportunity to secure a little more room for growth feels reassuring. It is important that we as a company now can use the successes we had during the year and increase the conditions for delivering more revenue streams. "- says Mohan Frick, CEO
This disclosure contains information that ChemoTech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 20-12-2021 20:30 CET.